BioInvent's Tie-Up With Cancer Research Technology Brings Some Relief From Pipeline Setbacks
This article was originally published in The Pink Sheet Daily
Executive Summary
Sweden's BioInvent forges links with researchers at Queen Mary, University of London, and Cancer Research Technology, the commercial arm of charity Cancer Research UK, to identify new therapeutic antibodies for oncology.